Alx Oncology Holdings Inc. (ALXO)
NASDAQ · Healthcare
Alx Oncology Holdings Inc. Revenue 2018–2022
Alx Oncology Holdings Inc. annual/quarterly revenue history and growth rate from 2018 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Alx Oncology Holdings Inc. revenue for the quarter ending June 30, 2020 was 527000, a 59.31% decrease year-over-year.
- Alx Oncology Holdings Inc. revenue for the twelve months ending June 30, 2020 was 3.7 M.
- Alx Oncology Holdings Inc. annual revenue for 2022 was 0.
- Alx Oncology Holdings Inc. annual revenue for 2021 was 0, a 100.00% decrease from 2020.
- Alx Oncology Holdings Inc. annual revenue for 2020 was 1.2 M, a 75.35% decrease from 2019.
- Alx Oncology Holdings Inc. annual revenue for 2019 was 4.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Alx Oncology Holdings Inc. Market Cap — FAQ
Alx Oncology Holdings Inc. (ALXO) market cap over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALXO's market cap history?
The chart and table above show Alx Oncology Holdings Inc.'s market cap by year and by quarter, including the growth rate.